Jean-Jacques Bienaim
Overview
Jean-Jacques Bienaim received an average of $12M in total compensation, including $941K in salary, at BioMarin Pharmaceutical from 2006 to 2021.
2021BioMarin PharmaceuticalCEO
2020BioMarin PharmaceuticalChief Executive Officer
2019BioMarin PharmaceuticalChief Executive Officer
2018BioMarin PharmaceuticalChief Executive Officer
2017BioMarin PharmaceuticalChief Executive Officer
2016BioMarin PharmaceuticalChief Executive Officer
2015BioMarin PharmaceuticalChief Executive Officer
2014BioMarin PharmaceuticalChief Executive Officer
2013BioMarin PharmaceuticalChief Executive Officer
2012BioMarin PharmaceuticalChief Executive Officer
Source: SEC filings on April 12, 2022, April 13, 2021, April 14, 2020, April 23, 2019, April 25, 2017, April 25, 2016, April 23, 2015, April 21, 2014, March 23, 2012, March 29, 2011, and April 30, 2007.
Related executives
We found 11 more executives who work or worked at BioMarin Pharmaceutical.
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
Robert Baffi
BioMarin Pharmaceutical
Former President of Global Manufacturing and Technical Operations
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
G Davis
BioMarin Pharmaceutical
General Counsel
Stephen Aselage
BioMarin Pharmaceutical
Executive Vice President & Chief Business Officer
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019